Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,710 total articles
Chiron Real Estate Inc. (NASDAQ:XRN) saw recent insider activity as director Paula Crowley acquired common stock in a transaction reported on May 11, 2026. The purchase, valued at approximately $34,000, occurred while the stock was trading near $33.54. This acquisition of 1,000 shares at a price of $34.00 per share brings Ms. Crowley's indirect own…
Michael Sentonas, the President of cybersecurity provider CrowdStrike Holdings Inc. (NASDAQ:CRWD), has completed a series of stock transactions totaling approximately $23.9 million. The sales, which involved 45,000 shares of Class A common stock, took place across two dates in May 2026. These disposals occurred while the company's stock was trading…
Jeffrey M. Stibel, the Chief Executive Officer of LegalZoom.com, Inc. (LZ), has significantly increased his direct stake in the company through a recent common stock acquisition. On May 11, 2026, Mr. Stibel purchased 125,000 shares in a transaction valued at approximately $768,987. This move comes amid a period of varied financial performance for t…
George Kurtz, the President and Chief Executive Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), has completed a sale of company stock totaling $990,448. The transaction involved 2,002 shares of Class A common stock and took place on May 8, 2026. These sales were conducted under a pre-arranged 10b5-1 trading plan that had been established earli…
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) director Sameer K. Gandhi has completed a sale of Class A common stock totaling approximately $9.23 million. The transaction, which occurred on May 8, 2026, was carried out through a 10b5-1 trading plan that had been established on June 27, 2025. This move comes at a time when the cybersecurity firm is navig…
Andrew Pardo Wright, serving as a Director at Slide Insurance Holdings, Inc. (SLDE), has completed a sale of common stock valued at approximately $119,372. The transaction occurred on May 7, 2026, involving the disposal of 6,316 shares at a price point of $18.90 per share. These assets were held indirectly via MAOV Slide, LLC, an entity where Mr. W…
George Kurtz, the President and Chief Executive Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), has completed the sale of 2,999 shares of Class A common stock. The total value realized from these transactions reached $1,546,245. Executed on May 7 and May 8, 2026, the sales occurred within a price range between $487.26 and $508.41 per share.The…
Lucas Shannon, serving as the President and Chief Operating Officer of Slide Insurance Holdings, Inc. (NASDAQ: SLDE), has completed two separate transactions involving the sale of common stock. These sales, which occurred in early May 2026, resulted in a total liquidation of approximately $491,262 worth of shares. The transactions were conducted un…
Bruce Lucas, the Chief Executive Officer of Slide Insurance Holdings, Inc. (NASDAQ: SLDE), has completed a series of stock sales totaling approximately $4.97 million. These transactions, which were executed via an indirect entity, took place in early May 2026. The divestments were part of a pre-arranged 10b5-1 trading plan that had been established…
Bryan Giraudo, a director at Protagonist Therapeutics, Inc. (NASDAQ: PTGX), has completed a series of stock transactions totaling approximately $5.92 million. These movements, which included both the exercise of stock options and the subsequent sale of common stock, took place on May 7 and May 8, 2026, according to recent SEC filings. While the com…
Expensify, Inc. (NASDAQ:EXFY) Chief Executive Officer David Michael Barrett has completed a sale of company stock totaling $32,400. The transaction, which involved 30,000 shares of Class A Common Stock, took place on May 1, 2026. This move by the top executive occurs against a backdrop of significant recent volatility for EXFY, as the company grapp…
Dylan C. Smith, the Chief Financial Officer of Box, Inc. (NASDAQ: BOX), has completed the sale of Class A Common Stock totaling $592,093. The transactions, which occurred on May 11, 2026, were executed in accordance with a Rule 10b5-1 trading plan that Smith had previously established on May 29, 2025. These scheduled sales took place as the company…
Jitendra Mohan, the Chief Executive Officer and a director of Astera Labs, Inc. (NASDAQ:ALAB), has completed a sale of common stock totaling approximately $28.01 million. The transaction, which took place on May 7, 2026, involved the disposal of 140,951 shares. This divestment was conducted through an automated process under a Rule 10b5-1 trading p…
Olivia Nottebohm, the Chief Operating Officer of Box Inc. (NASDAQ: BOX), has completed a sale of company stock totaling $313,882. The transaction involved 12,470 shares of Class A Common Stock and was conducted on May 8, 2026. This divestment was carried out under a Rule 10b5-1 trading plan that Nottebohm had established previously on July 9, 2025.…
James V. Caruso, the Chief Executive Officer of Cellectar Biosciences, Inc. (NASDAQ: CLRB), has executed a series of transactions to increase his direct ownership in the company. On May 7, 2026, Mr. Caruso purchased 8,680 shares of common stock at a price of $2.88 per share, representing a total investment of $24,998. This acquisition brings his to…
Jarrod Longcor, the Chief Operating Officer of Cellectar Biosciences, Inc. (NASDAQ:CLRB), has executed a series of transactions involving both common stock and warrants. On May 7, 2026, Longcor purchased 8,680 shares of common stock at a price of $2.88 per share, representing a total investment of $24,998. This activity comes as the company navigat…
Sarbani Chaudhuri, serving as the Chief Commercial and Medical Affairs Officer for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), recently completed a transaction involving the sale of company common stock. On May 7, 2026, Ms. Chaudhuri sold 17,650 shares of Rocket Pharmaceuticals common stock at a price per share of $3.838. This transaction resulted…
Alexandra Seros, a 10% owner of Entravision Communications Corp (NASDAQ:EVC), along with the Seros Ulloa Family Trust of 1996, have completed a series of stock sales totaling approximately $10.68 million. These transactions occurred over a five-day window in May 2026, coinciding with a period of intense upward momentum for EVC shares, which have se…
Christopher A. Scott, serving as Senior Vice President at Matson, Inc. (NASDAQ: MATX), has completed a sale of company stock. The transaction involved 3,305 shares of common stock, executed on May 8, 2026. The shares were sold at a price point of $180.14 each, which resulted in total proceeds of $595,362. Following this divestment, Mr. Scott mainta…
Taira Thomas, who serves as the President of Special Projects for Carvana Co. (NASDAQ: CVNA), has completed the sale of Class A Common Stock totaling $447,030. These transactions, which took place on May 8, 2026, were executed through a Rule 10b5-1 trading plan that had been established by Ms. Thomas on August 8, 2025. The sales occurred at price p…
Stefan A. Dyckerhoff, a member of the board of directors at Astera Labs, Inc. (NASDAQ: ALAB), has completed the sale of 12,599 shares of common stock. The transactions, which took place on May 7, 2026, resulted in an aggregate value of $2,500,211. These sales were conducted according to a Rule 10b5-1 trading plan that Mr. Dyckerhoff had established…
Kevin Allen Lansberry, a director at Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), executed a significant purchase of company common stock on May 7, 2026. The transaction involved the acquisition of 11,400 shares at an average price of $17.28 per share, totaling a $196,992 investment. This move increases Mr. Lansberry's direct holdings in the c…
Sylebra Capital LLC, acting in its capacity as a director for Impinj Inc. (NASDAQ: PI), has completed a notable divestment of the company's common stock. On May 7, 2026, the entity sold 36,171 shares at a price point of $152.73 per share. This transaction resulted in total proceeds of approximately $5,524,396. Following this disposal, Sylebra Capit…
Peter A. Thompson, a director at Sionna Therapeutics, Inc. (NASDAQ: SION), has completed the sale of 292,952 shares of common stock. The transactions, totaling approximately $13.36 million, were conducted in May 2026 and highlight significant insider movement while the company progresses through critical clinical trial phases for cystic fibrosis tr…
Gary Loeb, who serves as the Executive Vice President and Chief Legal and Compliance Officer for Intuitive Surgical Inc (NASDAQ:ISRG), recently completed a sale of company stock. On May 11, 2026, Mr. Loeb sold 400 shares of common stock at a price of $446.95 per share, resulting in total proceeds of $178,780. This transaction was carried out under …
